文献速递间质性肺疾病

步速与特发性肺纤维化患者预后:前瞻性队列研究

Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study.
PubMed 文献 · Eur Respir J · 2019-02-07

该前瞻性队列研究纳入130例新诊断特发性肺纤维化(IPF)门诊患者,基线测量4米步速(4MGS)和肺功能,随访1年记录生存状态和非计划住院。连续4MGS和慢4MGS是全因死亡和非计划住院的独立预测因子,含4MGS的多变量模型对死亡的区分度优于性别、年龄和肺生理指数或复合生理指数。

要点

  • 4MGS是IPF患者全因死亡和非计划住院的独立预测因子。
  • 慢4MGS与全因死亡风险升高相关(HR 2.63)。
  • 含4MGS模型对死亡区分度优于传统预后指数。

核心结论

  • 在IPF患者中,4MGS是全因死亡和非计划住院的独立预测因子。

研究设计与样本

  • 前瞻性队列研究,纳入130例新诊断IPF门诊患者,基线测量4MGS和肺功能,随访1年。

主要发现

  • 连续4MGS预测全因死亡(HR 0.03,95%CI 0.01-0.31;p=0.004)和非计划住院(HR 0.02,95%CI 0.01-0.14;p<0.001)。
  • 慢4MGS预测全因死亡(HR 2.63,95%CI 1.01-6.87;p=0.049)和非计划住院(HR 2.76,95%CI 1.16-6.58;p=0.02)。
  • 含4MGS或慢4MGS的多变量模型对死亡预测区分度优于性别、年龄和肺生理指数或复合生理指数。

临床怎么用

  • 4MGS可作为IPF患者预后评估的简单物理性能指标。
  • 慢4MGS提示全因死亡和非计划住院风险升高,需加强随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The 4-m gait speed (4MGS), a simple physical performance measure and surrogate marker of frailty, consistently predicts adverse prognosis in older adults. We hypothesised that 4MGS could predict all-cause mortality and nonelective hospitalisation in patients with idiopathic pulmonary fibrosis (IPF).4MGS and lung function were measured at baseline in 130 outpatients newly diagnosed with IPF. Survival status and nonelective hospital admissions were recorded over 1 year. We assessed the predictive value of 4MGS (as a continuous variable and as a binary variable: slow versus preserved 4MGS) by calculating hazard ratios using Cox proportional regression, adjusting for potential confounding variables. Receiver operating characteristic curves assessed discrimination between the multivariable regression models and established prognostic indices.Continuous 4MGS and slow 4MGS were independent predictors of all-cause mortality (4MGS: HR 0.03, 95% CI 0.01-0.31; p=0.004; slow 4MGS: 2.63, 95% CI 1.01-6.87; p=0.049) and hospitalisation (4MGS: HR 0.02, 95% CI 0.01-0.14; p<0.001; slow 4MGS: 2.76, 95% CI 1.16-6.58; p=0.02). Multivariable models incorporating 4MGS or slow 4MGS had better discrimination for predicting mortality than either the gender, age and lung physiology index or Composite Physiologic Index.In patients with IPF, 4MGS is an independent predictor of all-cause mortality and nonelective hospitalisation.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Nolan CM, Maddocks M, Maher TM, et al. Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study. Eur Respir J. 2019. PMID: 30487200. doi:10.1183/13993003.01186-2018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。